Avelina Karin Conde-knape PhD

Dr. Conde-Knape is responsible for setting up and driving the research and translational strategy in the areas of Cardiovascular and Liver disease within Novo Nordisk Global Drug Discovery. She has experience in the pharmaceutical industry for the last 16 years with different areas of responsibility, including project leadership, line management, strategic planning, and execution as well as business development. Karin spent 11 years at Hoffmann-La Roche in the Cardiovascular and Metabolism Discovery and early development areas, responsible for pharmacology teams as well as discovery and biomarker teams. Last 4 years she was at Johnson and Johnson, responsible for external innovation in Europe and the Asia Pacific in the area of Cardiovascular and Metabolism. During these years she leads cross-functional teams responsible for evaluating external opportunities and creating the business case to support deal-making for different opportunities.